|Year : 2019 | Volume
| Issue : 6 | Page : 203-207
Antimicrobial activity of Curcuma longa L. extract on periodontal pathogens
Mohammad Jalaluddin1, Ipsita Jayanti1, Inderjit Murugendrappa Gowdar2, Rincy Roshan3, Roshan Rajan Varkey3, Abhilash Thirutheri4
1 Department of Periodontics and Oral Implantology, Kalinga Institute of Dental Sciences, KIIT Deemed to be University, Bhubaneswar, Odisha, India
2 Department of Preventive Dental Sciences, College of Dentistry, Prince Sattam Bin Abdul Aziz University, Al-Kharj, Kingdom of Saudi Arabia
3 Department of Periodontics, Al-Azhar Dental College, Thodupuzha, Kerala, India
4 Department of Oral and Maxillofacial surgery, Sree Anjaneya Institute of Dental Sciences, Calicut, Kerala, India
|Date of Web Publication||28-May-2019|
Dr. Mohammad Jalaluddin
Department of Periodontics and Oral Implantology, Kalinga Institute of Dental Sciences, KIIT Deemed to be University, Bhubaneswar 751024, Odisha
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Aim: The aim of this study was to evaluate the antimicrobial activity of Curcuma longa L. extract (CLE) on periodontal pathogens. Materials and Methods: Sixty patients were divided into three groups: Group I (n = 20) patients treated with scaling and root planning (SRP) only, Group II (n = 20) patients treated with SRP followed by subgingival irrigation with 1% CLE solution, and Group III (n = 20) patients treated with SRP followed by subgingival irrigation with 0.2% chlorhexidine (CHX) solution. The clinical parameters (plaque index [PI], gingival index [GI] scores, probing pocket depths) were recorded at baseline, 4 weeks, and 8 weeks. The antimicrobial efficacy of 1% CLE and 0.2% CHX solutions against Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans were evaluated by disk diffusion method. Results: There was no significant difference in the mean values of zone of inhibition exhibited by both CLE and CHX solutions. All the groups showed significant improvement in the clinical parameters when compared to baseline values. The improvement in the PI and GI scores in the CLE group was lesser than that in CHX group by the end of the study period. Conclusion: CLE possess antimicrobial efficacy against the common periodontopathic bacteria. However, further large-scale studies evaluating the substantivity of C. longa are required to support its beneficial use in the treatment of periodontal diseases.
Keywords: Antimicrobial, Curcuma longa L, periodontal pathogens, pocket depth
|How to cite this article:|
Jalaluddin M, Jayanti I, Gowdar IM, Roshan R, Varkey R, Thirutheri A. Antimicrobial activity of Curcuma longa L. extract on periodontal pathogens. J Pharm Bioall Sci 2019;11, Suppl S2:203-7
|How to cite this URL:|
Jalaluddin M, Jayanti I, Gowdar IM, Roshan R, Varkey R, Thirutheri A. Antimicrobial activity of Curcuma longa L. extract on periodontal pathogens. J Pharm Bioall Sci [serial online] 2019 [cited 2021 May 12];11, Suppl S2:203-7. Available from: https://www.jpbsonline.org/text.asp?2019/11/6/203/258838
| Introduction|| |
Globally, periodontal diseases (chiefly gingivitis and periodontitis) are considered as one of the most common diseases affecting the oral cavity., The main etiological agent of the periodontal diseases is the persistent dental plaque. Periodontitis is a chronic inflammatory disease of the supporting tissues of the teeth. The untreated periodontitis eventually results in loss of teeth, thus negatively impacting mastication, nutrition, and quality of life in adults. Furthermore, periodontitis is closely associated with other medical conditions such as diabetes, heart disease, cancer, and chronic respiratory disease.,,
Of the several hundreds of microbial species that are present in the subgingival plaque, the bacteria that are most commonly isolated from the periodontal pockets in patients with chronic periodontitis are Porphyromonas gingivalis, Prevotella intermedia, and Aggregatibacter actinomycetemcomitans.
Scaling and root planning (SRP) is the standard treatment of care for periodontal diseases. Current reviews have summarized the beneficial effects of herbal medicines for periodontitis. One such kind is turmeric (also known as Curcuma longa) that belongs to the Zingiberaceae family. The role of curcumin in overpowering the actions of toll-like receptors (TLRs) has led to its identification and expansion as a potential therapeutic agent in controlling or stopping periodontitis.
The objective of this study was to investigate the efficacy of subgingival 1% Curcuma longa L. extract (CLE) as an adjunct to mechanical oral hygiene procedures and compare it with 0.2% chlorhexidine (CHX) solution, the gold standard among antiplaque agents.
[TAG:2]Materials and Methods[/TAG:2]
Sixty patients, aged between 25 and 45 years, who consented for the study, were selected from the Department of Periodontics, Kalinga Institute of Dental Sciences, Bhubaneswar, India. The included patients were healthy and free from any systemic disease. All the patients were diagnosed with chronic periodontitis and had probing pocket depth (PPD) of ≥5mm in different quadrants of the mouth. Patients who received periodontal treatment in the last 3 months, who had known history of systemic diseases and allergies, pregnancy, and used tobacco or tobacco related products, were excluded from the study.
The clinical parameters were recorded and subgingival plaque samples were collected from all the groups at baseline. Following this, Group I (n = 20) patients were treated with SRP only; Group II (n = 20) patients were treated with SRP followed by subgingival irrigation with 1% CLE solution; and Group III (n = 20) patients were treated with SRP followed by subgingival irrigation with 0.2% CHX solution. Patients were trained to maintain good plaque control. The subgingival irrigation was repeated at subsequent visits at 7 and 14 days. The clinical parameters were assessed again at 4 and 8 weeks.
The CLE solution (1%) was prepared by dissolving 1000 µg CLE in 5mL ethanol and 95mL glycerol. Commercially available 0.2% CHX was used.
The following clinical parameters were recorded at baseline, 4 weeks, and 8 weeks: plaque index (PI), gingival index (GI), and PPD (measured using a UNC-15 probe and standardized using acrylic stent with a groove so as to ascertain the point of entry of probe each time).
Microbiologic processing of samples
Each sterile paper point was inoculated into 5mL of brain heart infusion (BHI) broth and maintained anaerobically for 48 hours at 37°C and 5% CO2. Bacteria from BHI broth were then subcultured on tryptone soya agar (TSA) plates and kept at 37°C under anaerobic conditions in the presence of 5% CO2 for 72 hours. The pathogenic bacteria causing periodontitis were isolated and characterized as reported by Fani and Kohanteb.
Standard agar disk diffusion method was used to determine the inhibitory activity of both CLE and CHX. The test organisms were A. actinomycetemcomitans (ATCC 43727), P. gingivalis (ATCC 33287), and Prevotella intermedia (ATCC 25611). The respective bacterial strains were recovered by plating on blood agar medium. The isolated colonies were transferred to a sterile BHI broth and incubated again. The growth concentration was adjusted to 0.5 McFarland’s turbidity standard. After removing the excess inoculums, the agar plate was swabbed three times with intermittent rotation of the plates.
Three wells of 5mm diameters each were made on each plate using a hollow tube of 5mm diameter. Different concentrations of 1% CLE, 0.2% CHX mouthwash, and distilled water (negative control) were added in the wells allocating each plate for each of the solution. The inoculated plates were maintained under anaerobic conditions at 37°C for 48 hours. A digital vernier caliper was used to measure the diameter of zones of inhibition in all the wells in the plates. The mean values of zones of inhibition were calculated for each solution.
The data obtained were analyzed statistically using SPSS software. To compare the groups, analysis of variance was used followed by post hoc Tukey’s test.
| Results|| |
The mean scores of PI reduced significantly in all the groups when compared with the baseline values [Table 1]. Intergroup analysis [Table 2] and [Table 3] showed significant difference between the Groups I and II (P = 0.48, P = 0.44 at 4 and 8 weeks, respectively) and between the Groups I and III (P = 0.47, P = 0.001 at 4 and 8 weeks, respectively). At 4 weeks, no significant difference was noticed between Groups II and III. However, the mean (± SD) values for the PI scores in Group II (0.836±0.146) were more than those in Group III (0.602±0.126) at 8 weeks, with a significant difference (P = 0.49).
|Table 1: Comparison of plaque index scores at baseline, 4 weeks, and 8 weeks|
Click here to view
In this study, the GI decreased significantly in all the groups [Table 4]. By the fourth week, the test groups (CLE and CHX) demonstrated significantly better reduction in the GI scores compared with the control group. At 8 weeks, the reductions in the GI scores were significantly different between the test groups. The mean (± SD) values for GI scores [Table 5] increased from 4 weeks (0.814±0.437) to 8 weeks (0.906±0.133) in the CLE group. There was a significant difference (P = 0.27) between the test groups in the improvement of GI scores by 8 weeks.
|Table 4: Comparison of gingival index scores at baseline, 4 weeks, and 8 weeks|
Click here to view
|Table 5: Comparison of clinical parameters between the Groups II and III|
Click here to view
Periodontal probing depths
The values for PPDs reduced significantly in all the three groups [Table 6]. The reductions were least in the groups that were treated with SRP alone. The highest reductions were obtained in the CHX group compared to CLE group. However, the difference was not significant.
|Table 6: Comparison of probing pocket depth scores at baseline, 4 weeks, and 8 weeks|
Click here to view
The mean values of zone of inhibitions against A. actinomycetemcomitans, P. gingivalis, and Prevotella intermedia produced by CLE were 26.94±1.52, 23.81±1.35, and 21.83±1.66mm, respectively and those of CHX were 24.67±1.23, 24.92±1.22, and 23.71±1.41mm, respectively. There was no statistically significant difference between the test groups in the inhibition of growth of the common periodontopathic bacteria [Table 7].
| Discussion|| |
Periodontal diseases are silent diseases with a high global disease burden and related morbidity and socioeconomic effects. Mechanical removal of plaque is the backbone of periodontal therapy. As the etiology of periodontitis is manifold, the response to periodontal treatment is not universal. So, the dentists have to be aware of various available treatment approaches.
This study compared two local drug delivery systems, CLE and CHX subgingival irrigants. Curcumin has been recognized throughout the world for its numerous health benefits. Clinical use of curcumin as a possible adjunct in treating periodontitis has been studied by Gottumukkala et al., Bhatia et al., Nagasri et al., and several others. Although, curcumin is a known for its antibacterial properties, studies on the antibacterial efficacy of CLE against periodontal pathogens are limited in the literature.
Several studies have demonstrated the antibacterial properties of CHX. Chlorhexidine can destroy aerobic and anaerobic bacteria as well as fungi and viruses. On intragroup analysis, a significant reduction was found in the PI, GI, and PPD scores between all the groups but with more pronounced improvement in the test groups at 4 and 8 weeks, when compared to baseline. The improvements in the clinical parameters in the SRP group can be attributed to mechanical removal of subgingival plaque that contains disease-causing bacteria. This was in accordance with Ivić-Kardum et al. and Choi et al.
The inhibitory action of curcumin at different stages of the arachidonic acid inflammatory pathway explains its anti-inflammatory effects. Curcumin inhibits various inflammation-related enzymes and cytokines., Bhatia et al. and Nagasri et al. found similar results with improvement in the clinical parameters and a beneficial effect in patients with chronic periodontitis when curcumin was used as an adjunct to SRP.
Izui et al. used the standard strains of P. gingivalis, Prevotella intermedia, Fusobacterium nucleatum, and Treponema denticola and demonstrated their inhibition by curcumin at various concentrations. They could, however, not show the suppression of growth of A. actinomycetemcomitans. Similarly, Mandroli and Bhat used the standard strains of most predominant organisms of deep carious lesions namely Streptococcus mutans, Lactobacillus casei, A. actinomycetemcomitans, and most widespread strains of root canal bacteria, namely P. gingivalis, Prevotella intermedia, and Enterococcus faecalis. Their findings indicated the antibacterial activity of curcumin against all the investigated organisms except E. faecalis.
| Conclusion|| |
In this study we demonstrated CLEs as a potential subgingival irrigant. CLEs can be used as a better and safe alternative to CHX.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Petersen PE, Ogawa H. The global burden of periodontal disease: Towards integration with chronic disease prevention and control. Periodontol 2000 2012;60:15-39.
Chapple IL, Bouchard P, Cagetti MG, Campus G, Carra MC, Cocco F, et al
. Interaction of lifestyle, behaviour or systemic diseases with dental caries and periodontal diseases: Consensus report of group 2 of the joint EFP/ORCA workshop on the boundaries between caries and periodontal diseases. J Clin Periodontol 2017;44 (Suppl 18):S39-51.
James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, et al
. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database Syst Rev 2017;3:CD008676.
Kook KE, Kim C, Kang W, Hwang JK. Inhibitory effect of standardized curcuma xanthorrhiza
supercritical extract on LPS-induced periodontitis in rats. J Microbiol Biotechnol 2018;28:1614-25.
Livada R, Shiloah J, Tipton DA, Dabbous M. The potential role of curcumin in periodontal therapy: A review of the literature. J Inter Acad Periodontol 2017;19:70-9.
Tonetti MS, Jepsen S, Jin L, Otomo-Corgel J. Impact of the global burden of periodontal diseases on health, nutrition and wellbeing of mankind: A call for global action. J Clin Periodontol 2017;44:456–62.
Jacob PS, Nath S, Sultan OS. Use of curcumin in periodontal inflammation. Interdiscip J Microinflammation 2014;1:114.
Gartenmann SJ, Weydlich YV, Steppacher SL, Heumann C, Attin T, Schmidlin PR. The effect of green tea as an adjunct to scaling and root planing in non-surgical periodontitis therapy: A systematic review. Clin Oral Investig 2019;23:1-20.
Ara T, Nakatani S, Kobata K, Sogawa N, Sogawa C. The biological efficacy of natural products against acute and chronic inflammatory diseases in the oral region. Medicines 2018;5:122.
Fani M, Kohanteb J. Inhibitory activity of Aloe vera gel on some clinically isolated cariogenic and periodontopathic bacteria. J Oral Sci 2012;54:15-21.
Buset SL, Walter C, Friedmann A, Weiger R, Borgnakke WS, Zitzmann NU. Are periodontal diseases really silent? A systematic review of their effect on quality of life. J Clin Periodontol 2016;43:333-44.
Shaddox LM, Walker CB. Treating chronic periodontitis: Current status, challenges, and future directions. Clin Cosmet Investig Dent 2010;2:79-91.
Hewlings SJ, Kalman DS. Curcumin: A review of its’ effects on human health Foods 2017;6:92.
Gottumukkala SN, Koneru S, Mannem S, Mandalapu N. Effectiveness of sub gingival irrigation of an indigenous 1% curcumin solution on clinical and microbiological parameters in chronic periodontitis patients: A pilot randomized clinical trial. Contemp Clin Dent 2013;4:186-91.
] [Full text]
Bhatia M, Urolagin SS, Pentyala KB, Urolagin SB, K B M, Bhoi S. Novel therapeutic approach for the treatment of periodontitis by curcumin. J Clin Diagn Res 2014;8:ZC65-9.
Nagasri M, Madhulatha M, Musalaiah SV, Kumar PA, Krishna CH, Kumar PM. Efficacy of curcumin as an adjunct to scaling and root planning in chronic periodontitis patients: A clinical and microbiological study. J Pharm Bioallied Sci 2015;7:S554-8.
Lim KS, Kam PC. Chlorhexidine–pharmacology and clinical applications. Anaesth Intensive Care 2008;36:502-12.
Ivić-Kardum M, Jurak I, Gall-Trošelj K, Pavelić K, Aurer A, Ibrahimagić L. The effect of scaling and root planing on the clinical and microbiological parameters of periodontal diseases. Acta Stomat Croat 2001;35:39-42.
Choi YM, Lee JY, Choi J, Joo JY. Effect of root planing on the reduction of probing depth and the gain of clinical attachment depending on the mode of interproximal bone resorption. J Periodontal Implant Sci 2015;45:184-9.
Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric (Curcuma longa
). J Altern Complement Med 2003;9:161-8.
García-Caballero L, Quintas V, Prada-López I, Seoane J, Donos N, Tomás I. Chlorhexidine substantivity on salivary flora and plaque-like biofilm: An in situ model. PLoS One 2013;8:e83522.
Izui S, Sekine S, Maeda K, Kuboniwa M, Takada A, Amano A, et al
. Antibacterial activity of curcumin against periodontopathic bacteria. J Periodontol 2016;87:83-90.
Mandroli PS, Bhat K. An in-vitro evaluation of antibacterial activity of curcumin against common endodontic bacteria. JAPS 2013;3:106-8.
[Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]